Note: This message is displayed if (1) your browser is not standards-compliant or (2) you have you disabled CSS. Read our Policies for more information.
An INSPECT report summarizes the controlled substances a patient has been prescribed, the practitioner who prescribed them and the dispensing pharmacy where the patient obtained them.
Professional Licensing Agency
Attn: INSPECT Program
402 W. Washington Street, Room W072
Indianapolis, Indiana 46204
Phone Number: 317-234-4458
Helpdesk Support: (844) 446-4767
INSPECT Helpdesk E-mail: INRxReport@appriss.com
Office Hours: 8:00 a.m. to 4:30 p.m. Monday through Friday
INSPECT was designed to serve as a tool to address the problem of prescription drug abuse and diversion in Indiana. By compiling controlled substance information into an online database INSPECT performs two critical functions:
1. Maintain a clearinghouse of patient information for health care professionals.
2. Provide an important investigative tool for law enforcement.
INSPECT seeks to enhance the ability of prescribers such as physicians, advanced practice nurses, physicians assistants and dispensers as they perform critical public health functions. The program does this while maintaining the security of Hoosiers’ important prescription information.
The Indiana General Assembly passed legislation in the mid-1990s that required the collection of controlled substance data through the Central Repository for Controlled Substances Data.
At its inception, Indiana’s Prescription Monitoring program required licensed pharmacies in Indiana to report on dispensed schedule II controlled substances. In early 2004, grant funding and an act of the Legislature helped create INSPECT in its present form, expanding reporting requirements to include schedule II through V controlled substances. The program requires 24-hour reporting, providing nearly real-time data to practitioners.
INSPECT is funded at the state level by controlled substance licensing fees. Additionally, INSPECT continues to fulfill its obligations under the Harold Rogers and SAMHSA grant programs.
The INSPECT application is accessible only to registered users and available only through a secure website maintained by Program Staff.
July 1, 2016 - Pursuant to Indiana Code 25-26-13-4, ephedrine and pseudoephedrine, when dispensed via prescription, are each considered a "controlled substance" for the purposes of the INSPECT program. All prescription dispensations of these drugs must be reported to INSPECT. Over-the-counter purchases are not reported to INSPECT and must be processed through NPLEx.
January 1, 2016 - All controlled substances dispensed, including zero reports, must be reported within twenty-four (24) hours or by the close of the next business day if the dispenser is closed the day following the dispensing. Additionally, all errant records must be corrected and resubmitted within twenty-four (24) hours (next business day.)